Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Venous Thrombosis × Bevacizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 28 Carcinoma, Hepatocellular 14 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 8 Glioblastoma 6 Colonic Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 5 Liver Neoplasms 5 Rectal Neoplasms 4 Neoplasm Metastasis 4 Stomach Neoplasms 3 Sarcoma 3 Melanoma 3 Colorectal Cancer Metastatic 3 Carcinoma, Renal Cell 3 Carcinoma 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Nasopharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Endometrial Neoplasms 2

Interventions

atezolizumab 1 abelacimab 1 MAA868 1 Dalteparin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04649489 2026-01-15

TALENTOP

Fudan University

Phase 3 Active not recruiting

Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡